Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

67.72

-2.37 (-3.38%)

At close: Nov 6, 2025, 4:00 PM EST

66.69

-1.03 (-1.52%)

Pre-market: Nov 7, 2025, 8:38 AM EST

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Nov '25 Nov 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	3,480	1,985	1,376	719	486	511	Upgrade
Market Cap Growth	85.39%	44.25%	91.51%	47.79%	-4.80%	-7.70%	Upgrade
Enterprise Value	3,424	2,018	1,378	535	299	380	Upgrade
Last Close Price	67.72	41.35	29.52	19.50	15.95	17.46	Upgrade
PS Ratio	7.08	5.89	7.38	9.32	25.41	-	Upgrade
PB Ratio	11.90	8.80	5.53	5.06	4.04	2.97	Upgrade
P/TBV Ratio	57.86	-	-	8.65	4.79	2.97	Upgrade
P/FCF Ratio	78.53	212.71	-	-	-	-	Upgrade
P/OCF Ratio	77.87	192.25	-	-	-	-	Upgrade
EV/Sales Ratio	7.26	5.99	7.39	6.95	15.62	-	Upgrade
EV/FCF Ratio	77.25	216.27	-	-	-	-	Upgrade
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02	Upgrade
Debt / FCF Ratio	7.19	34.05	-	-	-	-	Upgrade
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-	Upgrade
Inventory Turnover	4.16	3.65	3.38	3.50	-	-	Upgrade
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56	Upgrade
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80	Upgrade
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%	Upgrade
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%	Upgrade
Return on Capital (ROIC)	-4.50%	-9.95%	-19.46%	-61.42%	-72.69%	-42.14%	Upgrade
Earnings Yield	-1.19%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%	Upgrade
FCF Yield	1.27%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%	Upgrade
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q